{"url_path":"/sec/rcel/8-k/2026-08-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-08-11","source_url":"https://www.sec.gov/Archives/edgar/data/1762303/0001193125-26-344787-index.html","accession_number":"0001193125-26-344787","cik":"0001762303","ticker":"RCEL","issuer_name":"AVITA Medical, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1762303/0001193125-26-344787-index.html","primary_entity_key":"0001762303","primary_entity_name":"AVITA Medical, Inc."},"word_count":140,"has_tables":true,"body_markdown":"## Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit No.\n\nDescription of Exhibit\n\n10.1\n\n[Global Amendment to the Contract Manufacturing Agreement and Exclusive Distribution Agreement between the registrant and Stedical Scientific, Inc. *](rcel-ex10_1.htm)\n\n104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n* Certain confidential portions of this exhibit have been omitted and redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K because the identified information is both not material and is the type that the registrant treats as private or confidential and/or would be competitively harmful if publicly disclosed.\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\nAVITA MEDICAL, INC.\n\n \n\n \n\n \n\n \n\nDate:\n\nAugust 11, 2026\n\nBy:\n\n/s/ David O'Toole\n\n \n\n \n\n \n\nName: David O'Toole\nTitle: Chief Financial Officer"}